Exploring Metastability in Ising models: critical droplets, energy barriers and exit time
Mathematical Physics, Analysis and Geometry · 2025-09 · 28 (3)
DOI: 10.1007/s11040-025-09514-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathematical Physics, Analysis and Geometry, online erschienen am 24.07.2025. Verfasst von Vanessa Jacquier. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper provides an overview of the research on the metastable behaviour of the Ising model. We analyse the transition times from the set of metastable states to the set of the stable states by identifying the critical configurations that the system crosses with high probability during this transition and by computing the energy barrier that the system must overcome to reach the stable state starting from the metastable one. We describe the dynamical phase transition of the Ising model evolving under Glauber dynamics across various contexts, including different lattices, dimensions and anisotropic variants. The analysis is extended to related models, such as long-range Ising model, Blume-Capel and Potts models, as well as to dynamics like Kawasaki dynamics, providing insights into metastability across different systems.
Zitieren
APA
Jacquier, V. (2025). Exploring Metastability in Ising models: critical droplets, energy barriers and exit time. Mathematical Physics, Analysis and Geometry, 28(3). https://doi.org/10.1007/s11040-025-09514-2
Vancouver
Jacquier V. Exploring Metastability in Ising models: critical droplets, energy barriers and exit time. Mathematical Physics, Analysis and Geometry. 2025;28(3). doi:10.1007/s11040-025-09514-2
BibTeX
@article{Jacquier2025,
author = {Jacquier, Vanessa},
title = {Exploring Metastability in Ising models: critical droplets, energy barriers and exit time},
journal = {Mathematical Physics, Analysis and Geometry},
year = {2025},
volume = {28},
number = {3},
doi = {10.1007/s11040-025-09514-2}
}
EUVIMED